(The Washington Post)
Up next in National
2:53
0:52
3:57
0:37
National
Advocate urges those with Down syndrome be included in Alzheimer's clinical trials
March 14, 2022 | 2:11 PM GMT
Individuals with Down syndrome are highly likely to develop Alzheimer’s disease as they enter middle age. Advocates like Karen Gaffney are pushing to include them in clinical trials.